These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9690549)

  • 21. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
    Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
    J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases.
    Ghossein R; Ganly I; Biagini A; Robenshtok E; Rivera M; Tuttle RM
    Thyroid; 2014 Feb; 24(2):245-53. PubMed ID: 23745671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of locoregional recurrences and distant metastases on the survival of patients with papillary thyroid carcinoma.
    Su DH; Chang SH; Chang TC
    Clin Endocrinol (Oxf); 2015 Feb; 82(2):286-94. PubMed ID: 24863061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does the T1 subdivision correlate with the risk of recurrence of papillary thyroid cancer?
    Chereau N; Trésallet C; Noullet S; Godiris-Petit G; Tissier F; Leenhardt L; Menegaux F
    Langenbecks Arch Surg; 2016 Mar; 401(2):223-30. PubMed ID: 26957089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors for papillary thyroid cancer persistence and recurrence: a retrospective analysis with a 10-year follow-up cohort study.
    de Castro TP; Waissmann W; Simões TC; de Mello RC; Carvalho DP
    Clin Endocrinol (Oxf); 2016 Sep; 85(3):466-74. PubMed ID: 26834009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Differentiated microcarcinoma of the thyroid gland in 45 cases].
    Wang J; Qiu X; Zhou L; Deng X; Zhang C; Zhou C
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 15(12):542-3. PubMed ID: 12541722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management.
    Chéreau N; Buffet C; Trésallet C; Tissier F; Leenhardt L; Menegaux F
    Surgery; 2016 Mar; 159(3):755-62. PubMed ID: 26435440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does extracapsular extension impact the prognosis of papillary thyroid microcarcinoma?
    Chéreau N; Buffet C; Trésallet C; Tissier F; Golmard JL; Leenhardt L; Menegaux F
    Ann Surg Oncol; 2014 May; 21(5):1659-64. PubMed ID: 24394985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.
    Byeon HK; Ban MJ; Lee JM; Ha JG; Kim ES; Koh YW; Choi EC
    Ann Surg Oncol; 2012 Dec; 19(13):4259-61. PubMed ID: 23070784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological pattern of lymph node recurrence of papillary thyroid cancer. Implications for surgery.
    Conzo G; Mauriello C; Docimo G; Gambardella C; Thomas G; Cavallo F; Tartaglia E; Napolitano S; Varriale R; Rossetti G; Fei L; Santini L
    Int J Surg; 2014; 12 Suppl 1():S194-7. PubMed ID: 24862675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
    Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
    Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cervical Lymph Node Metastases After Thyroidectomy for Papillary Thyroid Carcinoma Usually Remain Stable for Years.
    Tomoda C; Sugino K; Matsuzu K; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Ito K
    Thyroid; 2016 Dec; 26(12):1706-1711. PubMed ID: 27616725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.
    Leboulleux S; Rubino C; Baudin E; Caillou B; Hartl DM; Bidart JM; Travagli JP; Schlumberger M
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5723-9. PubMed ID: 16030160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Papillary thyroid microcarcinoma: prognostic factors and treatment.
    Besic N; Pilko G; Petric R; Hocevar M; Zgajnar J
    J Surg Oncol; 2008 Mar; 97(3):221-5. PubMed ID: 18050283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival.
    Akslen LA; Varhaug JE
    Cancer; 1995 Nov; 76(9):1643-54. PubMed ID: 8635070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasive well-differentiated thyroid carcinoma: effect of treatment modalities on outcome.
    Segal K; Shpitzer T; Hazan A; Bachar G; Marshak G; Popovtzer A
    Otolaryngol Head Neck Surg; 2006 May; 134(5):819-22. PubMed ID: 16647541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group.
    La Quaglia MP; Black T; Holcomb GW; Sklar C; Azizkhan RG; Haase GM; Newman KD
    J Pediatr Surg; 2000 Jun; 35(6):955-9; discussion 960. PubMed ID: 10873043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Papillary thyroid carcinoma: factors influencing recurrence and survival.
    Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
    Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.